RecruitingPhase 3NCT03127267
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AB Science
- Principal Investigator
- Albert Ludolph, MD, PhDDepartment of Neurology, University of Ulm, Germany
- Intervention
- Masitinib (6.0)(drug)
- Enrollment
- 495 enrolled
- Eligibility
- 18-81 years · All sexes
- Timeline
- 2021 – 2027
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- University of Southern California, Los Angeles, California, United States
- University of Kentucky, Lexington, Kentucky, United States
- Johns Hopkins Medicine Brain Science Institute, Baltimore, Maryland, United States
- Lahey Hospital and Medical Center, Burlington, Massachusetts, United States
- University of Virginia Health System, Charlottesville, Virginia, United States
- University Hospital Leuven (UZ Leuven), Leuven, Belgium
- Bispebjerg Hospital, Copenhagen, Denmark
- CHU de Angers, Angers, France
- Groupe Hospitalier Pellegrin Tripode, Bordeaux, France
- Hôpital neurologique Pierre Wertheimer, Bron, France
- CHU Gabriel Montpied, Clermont-Ferrand, France
- CHU de Lille - Hopital Roger Salengro, Lille, France
- CHU de Limoges - Hôpital Dupuytren, Limoges, France
- CHU de Marseille - Hôpital de la Timone, Marseille, France
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03127267 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)